SwiftSeq

SwiftSeq is a proprietary sequencing technology developed by SeqLL. It is designed for rapid and efficient next-generation sequencing of DNA and RNA. The core of SwiftSeq technology lies in its unique single-molecule sequencing approach, which avoids the need for amplification steps, thereby reducing bias and improving accuracy. This direct sequencing method allows for the detection of a wider range of genomic variations, including low-frequency variants.

The SwiftSeq platform utilizes a microfluidic device that captures and sequences individual DNA or RNA molecules. This integration of microfluidics with advanced sequencing chemistry is central to its speed and sensitivity. The technology is applied in various areas, including the detection of genetic mutations for cancer diagnostics, the analysis of microbial communities, and the study of gene expression. By minimizing sample preparation time and processing, SwiftSeq aims to accelerate the pace of genomic research and clinical applications. SeqLL emphasizes the cost-effectiveness and scalability of its SwiftSeq system, positioning it as a tool for both research laboratories and clinical settings.